CHANGZHOU, China, April 30, 2012 /PRNewswire-Asia-FirstCall/ --
China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a
leading domestic developer, manufacturer and marketer of orthopedic
implants in China, today announced
that the Company has filed its Annual Report on Form 20-F for the
year ended December 31, 2011 with the United States
Securities and Exchange Commission on April 30, 2012.
The Company's annual report on Form 20-F contains its audited
consolidated financial statements and is available on the Company's
website at http://ir.kanghui.com. The Company will provide a hard
copy of its completed audited financial statements free of charge
to its shareholders and ADS holders upon request.
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer,
manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of
proprietary orthopedic implant products in trauma and spine, and
has an extensive nationwide network of distributors for its
products in China, as well as in
28 other countries. Kanghui has strong research and development
capabilities, focused on developing new proprietary products and
product lines, and enhancing existing products and product lines.
For more information, please visit www.kanghui.com.
Contact:
China Kanghui Holdings Investor Relations Department
+1-888-321-2558
Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
carene.toh@asiabridgegroup.com
SOURCE China Kanghui Holdings